 | • レポートコード：QFJ1-4404 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、腎臓/腎線維化治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンジオテンシンII受容体拮抗薬（ARB）、アンジオテンシン変換酵素（ACE）阻害薬、ピルフェニドン、レニン阻害薬、バソペプチダーゼ阻害薬）、用途別市場規模（商業/私立病院、公衆衛生病院、クリニック、在宅治療）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・腎臓/腎線維化治療の市場動向 ・企業の競争状況、市場シェア ・腎臓/腎線維化治療の種類別市場規模と予測2016-2027（アンジオテンシンII受容体拮抗薬（ARB）、アンジオテンシン変換酵素（ACE）阻害薬、ピルフェニドン、レニン阻害薬、バソペプチダーゼ阻害薬） ・腎臓/腎線維化治療の用途別市場規模と予測2016-2027（商業/私立病院、公衆衛生病院、クリニック、在宅治療） ・腎臓/腎線維化治療の北米市場規模2016-2027（アメリカ、カナダ） ・腎臓/腎線維化治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・腎臓/腎線維化治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腎臓/腎線維化治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・腎臓/腎線維化治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Galectin Therapeutics、Merck & Co.、F. Hoffman-La Roche Ltd.、Pfizer Inc.、InterMune Inc.、ProMetic Life-Sciences Inc.、La Jolla Pharmaceutical Company、Genzyme Corporation、BioLine Rx Ltd） ・結論 |
Kidney/Renal fibrosis, defined as an aberrant wound healing process in response to chronic injury, is characterized by the progressive and persistent accumulation of extracellular matrix components (ECM) in the kidney, ultimately leading to renal failure.
Market Analysis and Insights: Global Kidney/Renal Fibrosis Treatment Market
The global Kidney/Renal Fibrosis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Kidney/Renal Fibrosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Kidney/Renal Fibrosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Kidney/Renal Fibrosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Kidney/Renal Fibrosis Treatment market.
Global Kidney/Renal Fibrosis Treatment Scope and Market Size
Kidney/Renal Fibrosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Kidney/Renal Fibrosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Angiotensin II Receptor Blockers (ARBs)
Angiotensin Converting Enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Vasopeptidase Inhibitors
Segment by Application
Commercial/Private Hospitals
Public Health Hospitals
Clinics
Home Treatment
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Galectin Therapeutics
Merck & Co.
F. Hoffman-La Roche Ltd.
Pfizer Inc.
InterMune Inc.
ProMetic Life-Sciences Inc.
La Jolla Pharmaceutical Company
Genzyme Corporation
BioLine Rx Ltd
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney/Renal Fibrosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Angiotensin II Receptor Blockers (ARBs)
1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.4 Pirfenidone
1.2.5 Renin Inhibitors
1.2.6 Vasopeptidase Inhibitors
1.3 Market by Application
1.3.1 Global Kidney/Renal Fibrosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Commercial/Private Hospitals
1.3.3 Public Health Hospitals
1.3.4 Clinics
1.3.5 Home Treatment
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Kidney/Renal Fibrosis Treatment Market Perspective (2016-2027)
2.2 Kidney/Renal Fibrosis Treatment Growth Trends by Regions
2.2.1 Kidney/Renal Fibrosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Kidney/Renal Fibrosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Kidney/Renal Fibrosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Kidney/Renal Fibrosis Treatment Industry Dynamic
2.3.1 Kidney/Renal Fibrosis Treatment Market Trends
2.3.2 Kidney/Renal Fibrosis Treatment Market Drivers
2.3.3 Kidney/Renal Fibrosis Treatment Market Challenges
2.3.4 Kidney/Renal Fibrosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney/Renal Fibrosis Treatment Players by Revenue
3.1.1 Global Top Kidney/Renal Fibrosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Kidney/Renal Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Kidney/Renal Fibrosis Treatment Revenue
3.4 Global Kidney/Renal Fibrosis Treatment Market Concentration Ratio
3.4.1 Global Kidney/Renal Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney/Renal Fibrosis Treatment Revenue in 2020
3.5 Kidney/Renal Fibrosis Treatment Key Players Head office and Area Served
3.6 Key Players Kidney/Renal Fibrosis Treatment Product Solution and Service
3.7 Date of Enter into Kidney/Renal Fibrosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney/Renal Fibrosis Treatment Breakdown Data by Type
4.1 Global Kidney/Renal Fibrosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Type (2022-2027)
5 Kidney/Renal Fibrosis Treatment Breakdown Data by Application
5.1 Global Kidney/Renal Fibrosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Kidney/Renal Fibrosis Treatment Market Size (2016-2027)
6.2 North America Kidney/Renal Fibrosis Treatment Market Size by Type
6.2.1 North America Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Kidney/Renal Fibrosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2027)
6.3 North America Kidney/Renal Fibrosis Treatment Market Size by Application
6.3.1 North America Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Kidney/Renal Fibrosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2027)
6.4 North America Kidney/Renal Fibrosis Treatment Market Size by Country
6.4.1 North America Kidney/Renal Fibrosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Kidney/Renal Fibrosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Kidney/Renal Fibrosis Treatment Market Size (2016-2027)
7.2 Europe Kidney/Renal Fibrosis Treatment Market Size by Type
7.2.1 Europe Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Kidney/Renal Fibrosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2027)
7.3 Europe Kidney/Renal Fibrosis Treatment Market Size by Application
7.3.1 Europe Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Kidney/Renal Fibrosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2027)
7.4 Europe Kidney/Renal Fibrosis Treatment Market Size by Country
7.4.1 Europe Kidney/Renal Fibrosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Kidney/Renal Fibrosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Type
8.2.1 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Application
8.3.1 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Region
8.4.1 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Kidney/Renal Fibrosis Treatment Market Size (2016-2027)
9.2 Latin America Kidney/Renal Fibrosis Treatment Market Size by Type
9.2.1 Latin America Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Kidney/Renal Fibrosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Kidney/Renal Fibrosis Treatment Market Size by Application
9.3.1 Latin America Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Kidney/Renal Fibrosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Kidney/Renal Fibrosis Treatment Market Size by Country
9.4.1 Latin America Kidney/Renal Fibrosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Kidney/Renal Fibrosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Type
10.2.1 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Application
10.3.1 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Country
10.4.1 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Galectin Therapeutics
11.1.1 Galectin Therapeutics Company Details
11.1.2 Galectin Therapeutics Business Overview
11.1.3 Galectin Therapeutics Kidney/Renal Fibrosis Treatment Introduction
11.1.4 Galectin Therapeutics Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021)
11.1.5 Galectin Therapeutics Recent Development
11.2 Merck & Co.
11.2.1 Merck & Co. Company Details
11.2.2 Merck & Co. Business Overview
11.2.3 Merck & Co. Kidney/Renal Fibrosis Treatment Introduction
11.2.4 Merck & Co. Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021)
11.2.5 Merck & Co. Recent Development
11.3 F. Hoffman-La Roche Ltd.
11.3.1 F. Hoffman-La Roche Ltd. Company Details
11.3.2 F. Hoffman-La Roche Ltd. Business Overview
11.3.3 F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Introduction
11.3.4 F. Hoffman-La Roche Ltd. Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021)
11.3.5 F. Hoffman-La Roche Ltd. Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Kidney/Renal Fibrosis Treatment Introduction
11.4.4 Pfizer Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021)
11.4.5 Pfizer Inc. Recent Development
11.5 InterMune Inc.
11.5.1 InterMune Inc. Company Details
11.5.2 InterMune Inc. Business Overview
11.5.3 InterMune Inc. Kidney/Renal Fibrosis Treatment Introduction
11.5.4 InterMune Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021)
11.5.5 InterMune Inc. Recent Development
11.6 ProMetic Life-Sciences Inc.
11.6.1 ProMetic Life-Sciences Inc. Company Details
11.6.2 ProMetic Life-Sciences Inc. Business Overview
11.6.3 ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Introduction
11.6.4 ProMetic Life-Sciences Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021)
11.6.5 ProMetic Life-Sciences Inc. Recent Development
11.7 La Jolla Pharmaceutical Company
11.7.1 La Jolla Pharmaceutical Company Company Details
11.7.2 La Jolla Pharmaceutical Company Business Overview
11.7.3 La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Introduction
11.7.4 La Jolla Pharmaceutical Company Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021)
11.7.5 La Jolla Pharmaceutical Company Recent Development
11.8 Genzyme Corporation
11.8.1 Genzyme Corporation Company Details
11.8.2 Genzyme Corporation Business Overview
11.8.3 Genzyme Corporation Kidney/Renal Fibrosis Treatment Introduction
11.8.4 Genzyme Corporation Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021)
11.8.5 Genzyme Corporation Recent Development
11.9 BioLine Rx Ltd
11.9.1 BioLine Rx Ltd Company Details
11.9.2 BioLine Rx Ltd Business Overview
11.9.3 BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Introduction
11.9.4 BioLine Rx Ltd Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021)
11.9.5 BioLine Rx Ltd Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Kidney/Renal Fibrosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Angiotensin II Receptor Blockers (ARBs)
Table 3. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
Table 4. Key Players of Pirfenidone
Table 5. Key Players of Renin Inhibitors
Table 6. Key Players of Vasopeptidase Inhibitors
Table 7. Global Kidney/Renal Fibrosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Kidney/Renal Fibrosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Kidney/Renal Fibrosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Kidney/Renal Fibrosis Treatment Market Share by Regions (2016-2021)
Table 11. Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Kidney/Renal Fibrosis Treatment Market Share by Regions (2022-2027)
Table 13. Kidney/Renal Fibrosis Treatment Market Trends
Table 14. Kidney/Renal Fibrosis Treatment Market Drivers
Table 15. Kidney/Renal Fibrosis Treatment Market Challenges
Table 16. Kidney/Renal Fibrosis Treatment Market Restraints
Table 17. Global Kidney/Renal Fibrosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Kidney/Renal Fibrosis Treatment Market Share by Players (2016-2021)
Table 19. Global Top Kidney/Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney/Renal Fibrosis Treatment as of 2020)
Table 20. Ranking of Global Top Kidney/Renal Fibrosis Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Kidney/Renal Fibrosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Kidney/Renal Fibrosis Treatment Product Solution and Service
Table 24. Date of Enter into Kidney/Renal Fibrosis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Kidney/Renal Fibrosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Kidney/Renal Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Kidney/Renal Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Kidney/Renal Fibrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Kidney/Renal Fibrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Kidney/Renal Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Kidney/Renal Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Kidney/Renal Fibrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Kidney/Renal Fibrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Kidney/Renal Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Kidney/Renal Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Kidney/Renal Fibrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Kidney/Renal Fibrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Galectin Therapeutics Company Details
Table 65. Galectin Therapeutics Business Overview
Table 66. Galectin Therapeutics Kidney/Renal Fibrosis Treatment Product
Table 67. Galectin Therapeutics Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 68. Galectin Therapeutics Recent Development
Table 69. Merck & Co. Company Details
Table 70. Merck & Co. Business Overview
Table 71. Merck & Co. Kidney/Renal Fibrosis Treatment Product
Table 72. Merck & Co. Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 73. Merck & Co. Recent Development
Table 74. F. Hoffman-La Roche Ltd. Company Details
Table 75. F. Hoffman-La Roche Ltd. Business Overview
Table 76. F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Product
Table 77. F. Hoffman-La Roche Ltd. Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 78. F. Hoffman-La Roche Ltd. Recent Development
Table 79. Pfizer Inc. Company Details
Table 80. Pfizer Inc. Business Overview
Table 81. Pfizer Inc. Kidney/Renal Fibrosis Treatment Product
Table 82. Pfizer Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 83. Pfizer Inc. Recent Development
Table 84. InterMune Inc. Company Details
Table 85. InterMune Inc. Business Overview
Table 86. InterMune Inc. Kidney/Renal Fibrosis Treatment Product
Table 87. InterMune Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 88. InterMune Inc. Recent Development
Table 89. ProMetic Life-Sciences Inc. Company Details
Table 90. ProMetic Life-Sciences Inc. Business Overview
Table 91. ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Product
Table 92. ProMetic Life-Sciences Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 93. ProMetic Life-Sciences Inc. Recent Development
Table 94. La Jolla Pharmaceutical Company Company Details
Table 95. La Jolla Pharmaceutical Company Business Overview
Table 96. La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Product
Table 97. La Jolla Pharmaceutical Company Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 98. La Jolla Pharmaceutical Company Recent Development
Table 99. Genzyme Corporation Company Details
Table 100. Genzyme Corporation Business Overview
Table 101. Genzyme Corporation Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 102. Genzyme Corporation Recent Development
Table 103. BioLine Rx Ltd Company Details
Table 104. BioLine Rx Ltd Business Overview
Table 105. BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Product
Table 106. BioLine Rx Ltd Revenue in Kidney/Renal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 107. BioLine Rx Ltd Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kidney/Renal Fibrosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Angiotensin II Receptor Blockers (ARBs) Features
Figure 3. Angiotensin Converting Enzyme (ACE) Inhibitors Features
Figure 4. Pirfenidone Features
Figure 5. Renin Inhibitors Features
Figure 6. Vasopeptidase Inhibitors Features
Figure 7. Global Kidney/Renal Fibrosis Treatment Market Share by Application: 2020 VS 2027
Figure 8. Commercial/Private Hospitals Case Studies
Figure 9. Public Health Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Home Treatment Case Studies
Figure 12. Kidney/Renal Fibrosis Treatment Report Years Considered
Figure 13. Global Kidney/Renal Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Kidney/Renal Fibrosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Kidney/Renal Fibrosis Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Kidney/Renal Fibrosis Treatment Market Share by Regions (2022-2027)
Figure 17. Global Kidney/Renal Fibrosis Treatment Market Share by Players in 2020
Figure 18. Global Top Kidney/Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney/Renal Fibrosis Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Kidney/Renal Fibrosis Treatment Revenue in 2020
Figure 20. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Kidney/Renal Fibrosis Treatment Market Share by Type (2016-2027)
Figure 24. North America Kidney/Renal Fibrosis Treatment Market Share by Application (2016-2027)
Figure 25. North America Kidney/Renal Fibrosis Treatment Market Share by Country (2016-2027)
Figure 26. United States Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Kidney/Renal Fibrosis Treatment Market Share by Type (2016-2027)
Figure 30. Europe Kidney/Renal Fibrosis Treatment Market Share by Application (2016-2027)
Figure 31. Europe Kidney/Renal Fibrosis Treatment Market Share by Country (2016-2027)
Figure 32. Germany Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Share by Region (2016-2027)
Figure 42. China Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Kidney/Renal Fibrosis Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Kidney/Renal Fibrosis Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Kidney/Renal Fibrosis Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Galectin Therapeutics Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2016-2021)
Figure 62. Merck & Co. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2016-2021)
Figure 63. F. Hoffman-La Roche Ltd. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2016-2021)
Figure 64. Pfizer Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2016-2021)
Figure 65. InterMune Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2016-2021)
Figure 66. ProMetic Life-Sciences Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2016-2021)
Figure 67. La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2016-2021)
Figure 68. Genzyme Corporation Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2016-2021)
Figure 69. BioLine Rx Ltd Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
腎線維症治療のグローバル市場調査 2019年 The global Kidney (Renal) Fibrosis market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Kidney (Renal) Fibrosis volume and value at global level, regional level and company level. From a global perspecti…- 世界のアンジオテンシン変換酵素阻害剤市場規模・現状・予測（2021年-2027年） Angiotensin converting enzyme inhibitors (ACE inhibitors) are medications that slow (inhibit) the activity of the enzyme ACE, which decreases the production of angiotensin II. Market Analysis and Insights: Global Angiotensin Converting Enzyme Inhibitors Market The global Angiotensin Converting Enzym…
- レニン阻害剤のグローバル市場2021 Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the …
- 世界のICU（集中治療室）における急性腎治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global ICU-acquired Acute Kidney Treatment Market The global ICU-acquired Acute Kidney Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
- 世界の腎臓癌＆腎細胞癌（RCC）治療薬市場規模・現状・予測（2021年-2027年） Kidney cancer/ renal cell carcinoma (RCC) is among ten most commonly observed cancer these days. It is sixth common cancer observed in men and it is the tenth most common cause of cancer for women. Market Analysis and Insights: Global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market The glo…